血浆sRAGE作为脓毒症相关ARDS的遗传调控因果中介
本研究在脓毒症危重患者中评估血浆sRAGE是否为ARDS的因果中介。两个队列全基因组基因分型后,以孟德尔随机化推断因果,发现血浆sRAGE与ARDS风险强相关,且遗传工具估计的因果效应一致,提示sRAGE升高导致ARDS风险增加。
要点
- 血浆sRAGE与脓毒症患者ARDS风险强相关。
- 孟德尔随机化提示血浆sRAGE升高因果性增加ARDS风险。
- sRAGE可能作为脓毒症相关ARDS的因果中介。
核心结论
- 血浆sRAGE在脓毒症期间受遗传调控,孟德尔随机化分析表明血浆sRAGE升高导致ARDS风险增加,提示其作为脓毒症相关ARDS的因果中介。
研究设计与样本
- 在两个伴脓毒症的危重患者队列中测量早期血浆sRAGE,并进行全基因组基因分型和ARDS表型分析。
- 第一队列含393例欧洲裔和266例非洲裔患者,第二队列含843例欧洲裔患者。
- 以两个队列中均显著关联的顶级变异(P < 0.01,R2 > 0.02)作为遗传工具,采用逆方差加权法进行孟德尔随机化。
主要发现
- 血浆sRAGE与ARDS风险在两个人群中均强相关:第一队列比值比1.86(95%CI 1.54-2.25),第二队列2.56(95%CI 2.14-3.06),均为每对数增加。
- 使用两群体共有的遗传工具,血浆sRAGE对ARDS风险的因果效应β估计为0.50(95%CI 0.09-0.91),每对数增加。
临床怎么用
- 血浆sRAGE可作为脓毒症相关ARDS的因果中介生物标志物,支持进一步研究其作为干预靶点的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Acute respiratory distress syndrome (ARDS) lacks known causal biomarkers. Plasma concentrations of sRAGE (soluble receptor for advanced glycation end products) strongly associate with ARDS risk. However, whether plasma sRAGE contributes causally to ARDS remains unknown.Objectives: Evaluate plasma sRAGE as a causal intermediate in ARDS by Mendelian randomization (MR), a statistical method to infer causality using observational data.Methods: We measured early plasma sRAGE in two critically ill populations with sepsis. The cohorts were whole-genome genotyped and phenotyped for ARDS. To select validated genetic instruments for MR, we regressed plasma sRAGE on genome-wide genotypes in both cohorts. The causal effect of plasma sRAGE on ARDS was inferred using the top variants with significant associations in both populations (P < 0.01, R2 > 0.02). We applied the inverse variance-weighted method to obtain consistent estimates of the causal effect of plasma sRAGE on ARDS risk.Measurements and Main Results: There were 393 European and 266 African ancestry patients in the first cohort and 843 European ancestry patients in the second cohort. Plasma sRAGE was strongly associated with ARDS risk in both populations (odds ratio, 1.86; 95% confidence interval [1.54-2.25]; 2.56 [2.14-3.06] per log increase). Using genetic instruments common to both populations, plasma sRAGE had a consistent causal effect on ARDS risk with a β estimate of 0.50 (95% confidence interval [0.09-0.91] per log increase).Conclusions: Plasma sRAGE is genetically regulated during sepsis, and MR analysis indicates that increased plasma sRAGE leads to increased ARDS risk, suggesting plasma sRAGE acts as a causal intermediate in sepsis-related ARDS.
引用
- Jones TK, Feng R, Kerchberger VE, et al. Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020. PMID: 31487195. doi:10.1164/rccm.201810-2033OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。